Organisation paid for research Program year 2025 Source: CMS Open Payments

Vance Thompson Vision Clinic

Neither a doctor nor a teaching hospital

Research payments

$848,916

87 payments

Through program year 2025, Vance Thompson Vision Clinic is reported as receiving $848,916 in research payments, across 87 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $73,959 12
2024 Research $92,726 17
2023 Research $25,997 4
2022 Research $22,602 3
2021 Research $61,714 10
2020 Research $296,951 28
2019 Research $274,966 13

Breakdown

Who paid Research payments · program years 2019–2025
  1. Allergan Inc. $251,784 37 payments
  2. Carl Zeiss Meditec, Inc. $230,392 15 payments
  3. AbbVie, Inc. $192,683 33 payments
  4. Avedro Inc. $173,085 1 payment
  5. Novartis Pharmaceuticals Corporation $972 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. 308 $173,085 1 payment
  2. Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $101,708 13 payments
  3. A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $100,769 18 payments
  4. A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $75,824 12 payments
  5. Multicenter Double Masked Randomized Vehicle-Controlled Parallel-Group study of AGN-190584 for Participants with Presbyopia $75,191 7 payments
  6. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $44,152 1 payment
  7. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $43,900 1 payment
  8. A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma $35,725 7 payments
  9. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $29,630 1 payment
  10. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $27,970 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record